Dr. Rick Barnett is the Owner and Clinical Psychologist at BPS Health, LLC, a private online and in-person CBT practice. As the Co-founder of the Psychedelic Society of Vermont, he has been trained in psychedelic therapy and research, focusing on MDMA, psilocybin, and ketamine. Dr. Barnett is also an alcohol and drug addiction counselor.

In recent years, there has been a growing interest in psychedelic drug uses for mental health and addiction treatments. With evolving perspectives and beliefs about its use in psychotherapeutic settings, many clinicians are at odds about the potential benefits and risks. How can you navigate therapeutic use and potential misuse of these treatment methods?

With personal and professional experiences with psychedelics, Dr. Rick Barnett maintains that these therapies can facilitate profound personal growth, trauma integration, and addiction recovery in both clinical and nonclinical settings. By creating curated and safe environments with trained professionals, individuals can navigate deeply impactful experiences, often achieving shifts in awareness and healing. When utilizing psychedelics for addiction treatments, Dr. Barnett advocates for a balanced approach that blends harm reduction and abstinence-based philosophies to redefine recovery.

Tune in to the latest episode of Living Medicine as Dr. Sandy Newes hosts Dr. Rick Barnett, the Owner and Clinical Psychologist at BPS Health, LLC, to discuss psychedelic’s evolving role in addiction treatment and recovery. He shares his thoughts on at-home versus in-office ketamine treatments, his in-depth research and personal experience with 5-MeO-DMT, and how to leverage various psychedelics for separate treatments.